Citations (6)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (1)
Fatimah A. Alhammad, Khalid B Alburayk, Khadija S. Albadri, Sohail A. Butt & Faisal Azam. (2023) Treatment response and recurrence of conjunctival melanoma with orbital invasion treated with immune checkpoint inhibitors: case report and literature review. Orbit 0:0, pages 1-9.
Read now
Read now
Articles from other publishers (5)
Edgardo Castro‐Pérez, Mithalesh Singh, Shreyans Sadangi, Carmen Mela‐Sánchez & Vijayasaradhi Setaluri. (2023) Connecting the dots: Melanoma cell of origin, tumor cell plasticity, trans‐differentiation, and drug resistance. Pigment Cell & Melanoma Research.
Crossref
Crossref
Pau Cid-Bertomeu & Valentín Huerva. (2022) Use of interferon alpha 2b to manage conjunctival primary acquired melanosis and conjunctival melanoma. Survey of Ophthalmology 67:5, pages 1391-1404.
Crossref
Crossref
Jennifer Peil, Felix Bock, Friedemann Kiefer, Rebecca Schmidt, Ludwig M. Heindl, Claus Cursiefen & Simona L. Schlereth. (2022) New Therapeutic Approaches for Conjunctival Melanoma—What We Know So Far and Where Therapy Is Potentially Heading: Focus on Lymphatic Vessels and Dendritic Cells. International Journal of Molecular Sciences 23:3, pages 1478.
Crossref
Crossref
Mak B. Djulbegovic, Vladimir N. Uversky, J. William Harbour, Anat Galor & Carol L. Karp. (2021) Structural Protein Analysis of Driver Gene Mutations in Conjunctival Melanoma. Genes 12:10, pages 1625.
Crossref
Crossref
Simona D’Aguanno, Fabiana Mallone, Marco Marenco, Donatella Del Bufalo & Antonietta Moramarco. (2021) Hypoxia-dependent drivers of melanoma progression. Journal of Experimental & Clinical Cancer Research 40:1.
Crossref
Crossref